Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ESTABLISHMENT LABS HOLDINGS INC.

(ESTA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/16/2021 09/17/2021 09/20/2021 09/21/2021 09/22/2021 Date
71.4(c) 72.7(c) 70.53(c) 70.87(c) 71.63 Last
23 993 42 972 93 034 31 496 63 240 Volume
-0.20% +1.82% -2.98% +0.48% +1.07% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 125 M - -
Net income 2021 -29,2 M - -
Net cash position 2021 14,5 M - -
P/E ratio 2021 -58,2x
Yield 2021 -
Sales 2022 156 M - -
Net income 2022 -20,0 M - -
Net cash position 2022 23,4 M - -
P/E ratio 2022 -86,0x
Yield 2022 -
Capitalization 1 682 M 1 682 M -
EV / Sales 2021 13,4x
EV / Sales 2022 10,7x
Nbr of Employees 669
Free-Float 84,9%
More Financials
Company
Establishment Labs Holdings Inc. is a medical technology and aesthetics company that is focused on patient safety and aesthetic outcomes and also in the breast aesthetics and reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. Its line of silicone gel-filled breast implants,... 
More about the company
Ratings of Establishment Labs Holdings Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about ESTABLISHMENT LABS HOLDINGS INC.
09/14INSIDER SELL : Establishment Labs Holdings
MT
09/02ESTABLISHMENT LABS : Launches Motiva Flora Tissue Expander in Europe
MT
09/02ESTABLISHMENT LABS : Launches Motiva Flora Tissue Expander in Europe and Other CE Mark Cou..
BU
09/02Establishment Labs Launches Motiva Flora Tissue Expander in Europe and Other CE Mark Co..
CI
08/20ESTABLISHMENT LABS : to Launch Motiva Flora Tissue Expander at London Breast Meeting on Se..
BU
08/20Establishment Labs Holdings Inc. to Launch Motiva Flora Tissue Expander At London Breas..
CI
08/03ESTABLISHMENT LABS : Goldman Sachs Adjusts Establishment Labs Holdings' Price Target to $7..
MT
08/02ESTABLISHMENT LABS : Digital Health Firm Eko Names New Chief Financial Officer
MT
08/02ESTABLISHMENT LABS : Eko Appoints Renee Gaeta as Chief Financial Officer
AQ
08/02ESTABLISHMENT LABS : CORRECTING and REPLACING Establishment Labs Announces Participation i..
BU
07/30ESTABLISHMENT LABS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
07/29ESTABLISHMENT LABS : Earnings Flash (ESTA) ESTABLISHMENT LABS HOLDINGS Reports Q2 Revenue ..
MT
07/29ESTABLISHMENT LABS HOLDINGS INC. : Results of Operations and Financial Condition, Financia..
AQ
07/29ESTABLISHMENT LABS : Reports Record Second Quarter 2021 Financial Results and Raises Full ..
BU
07/29Establishment Labs Holdings Inc. Raises Revenue Guidance for the Year 2021
CI
More news
News in other languages on ESTABLISHMENT LABS HOLDINGS INC.
09/02Establishment Labs lance l'expandeur de tissus Motiva Flora en Europe
More news
Analyst Recommendations on ESTABLISHMENT LABS HOLDINGS INC.
More recommendations
Chart ESTABLISHMENT LABS HOLDINGS INC.
Duration : Period :
Establishment Labs Holdings Inc. Technical Analysis Chart | ESTA | VGG312491084 | MarketScreener
Technical analysis trends ESTABLISHMENT LABS HOLDINGS INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 70,87 $
Average target price 90,17 $
Spread / Average Target 27,2%
EPS Revisions
Managers and Directors
Juan JosÚ Chacˇn Quirˇs Chief Executive Officer & Director
Raj Denhoy Chief Financial Officer
Nicholas S. Lewin Chairman
Roberto de Mezerville Chief Technology Officer
Pratip Dastidar Global Head-Operations
Sector and Competitors
1st jan.Capi. (M$)
ESTABLISHMENT LABS HOLDINGS INC.88.28%1 682
ABBOTT LABORATORIES14.28%221 833
MEDTRONIC PLC9.13%172 048
BECTON, DICKINSON AND COMPANY3.51%74 382
HOYA CORPORATION28.03%62 177
SARTORIUS STEDIM BIOTECH84.00%57 875